A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Trial details
- Registry ID
- NCT07382167
- Drugs studied
- Tenapanor 25 mg BID, Tenapanor 5 mg BID, Tenapanor 50 mg BID
TrialRedline tracks 5 clinical trials sponsored by Ardelyx: 4 Phase 3, 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in AdultsNCT07382167 | Tenapanor 25 mg BID, Tenapanor 5 mg BID, Tenapanor 50 mg BID | Recruiting | 2027-02-26Estimated |
| Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-CNCT05905926 | Tenapanor | Enrolling by invitation | 2031-07Estimated |
| Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 YearsNCT05643534 | Tenapanor 25 mg bid, Tenapanor 50 MG | Completed | 2026-08-20Actual |
| A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on DialysisNCT03427125 | Sevelamer Carbonate, Tenapanor | Completed | 2019-11-15Actual |
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| 4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 YrsNCT06553547 | Tenapanor | Completed | 2026-07-07Actual |
Names as written in the registry records.
Before: Estimated. After: Actual.
Before: 1 Sep 2026. After: 20 Aug 2026.
Before: Active not recruiting. After: Completed.
NCT06553547 · Ardelyx
Before: Estimated. After: Actual.
Before: Jul 2026. After: 7 Jul 2026.
Before: Active not recruiting. After: Completed.
NCT06553547 · Ardelyx
Before: Estimated. After: Actual.
Before: Jun 2026. After: Jul 2026.
Before: Recruiting. After: Active not recruiting.
Before: Estimated. After: Actual.
Before: 1 Jun 2026. After: 1 Sep 2026.
Before: Recruiting. After: Active not recruiting.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Durable CSBM response. After: Measure: Durable complete spontaneous bowel movements (CSBM) response.
Before: 31 Dec 2025. After: 1 Jun 2026.